Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scalp Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05028582
What this trial is testing

Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)

Who this might be right for
Scalp Psoriasis
Arcutis Biotherapeutics, Inc. 432
Testing effectiveness (Phase 2)Study completedNCT01914627
What this trial is testing

Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

Who this might be right for
Scalp Psoriasis
G. Pohl-Boskamp GmbH & Co. KG 90
Testing effectiveness (Phase 2)Study completedNCT01120223
What this trial is testing

Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
LEO Pharma 78
Large-scale testing (Phase 3)Study completedNCT00438399
What this trial is testing

Subject Preference for Scalp Psoriasis Treatment

Who this might be right for
Scalp Psoriasis
Galderma R&D 219
Post-approval studies (Phase 4)Study completedNCT05478499
What this trial is testing

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 154
Not applicableStudy completedNCT05105139
What this trial is testing

Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp

Who this might be right for
Seborrheic DermatitisPsoriasis of Scalp
Laboratorios Silanes S.A. de C.V. 90
Large-scale testing (Phase 3)Study completedNCT03897088
What this trial is testing

Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries Limited 231
Not applicableStudy completedNCT01052467
What this trial is testing

Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

Who this might be right for
Scalp Psoriasis
LEO Pharma 724
Not applicableStudy completedNCT02856542
What this trial is testing

Real-life Evaluation of the Daivobet® Gel Applicator

Who this might be right for
Plaque Psoriasis
LEO Pharma 1,560
Not applicableStudy completedNCT06015152
What this trial is testing

Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Jinnah Postgraduate Medical Centre 90
Large-scale testing (Phase 3)Study completedNCT02933866
What this trial is testing

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 371
Testing effectiveness (Phase 2)Study completedNCT02933528
What this trial is testing

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00216879
What this trial is testing

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

Who this might be right for
Psoriasis of Scalp
LEO Pharma 800
Testing effectiveness (Phase 2)Study completedNCT02038569
What this trial is testing

An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 125
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Post-approval studies (Phase 4)Study completedNCT00881868
What this trial is testing

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Scalp Psoriasis
Galderma R&D 81
Large-scale testing (Phase 3)Active Not RecruitingNCT06095102
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 311
Large-scale testing (Phase 3)Study completedNCT00216827
What this trial is testing

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Who this might be right for
Psoriasis of Scalp
LEO Pharma 1,485
Post-approval studies (Phase 4)UnknownNCT01558310
What this trial is testing

Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis

Who this might be right for
Scalp PsoriasisPlaque Psoriasis
Paul Steven Yamauchi, MD, PhD 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation